This program summarizes the most important antitrust developments in the healthcare industry in the first quarter of 2024. Sectors covered include pharmaceuticals, group purchasing organizations, providers, healthcare technology, medical devices, and health insurers.
The content of this program does not meet requirements for continuing legal education (CLE) accreditation. You will not receive CLE credit for participating.
